FindMyRecallSubscribe
Class I: serious health riskOngoing

Dr. Reddy's Laboratories Levetiracetam 0 Recall

Levetiracetam 0

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class I
Reported by FDA
Apr 23, 2025
Recall ID
D-0365-2025
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Levetiracetam 0 starting Mar 13, 2025. The FDA classified it as Class I (serious health risk) and published enforcement report D-0365-2025 on Apr 23, 2025. Reason: LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL. Status: Ongoing.

Why it was recalled

LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.

Product description

Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland Pharma Limited, Hyderabad, - 500 043 INDIA, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-636-52

Lot numbers, UPCs & expiration codes

Lot: A1540076, Exp 08/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0365-2025
Classification
Class I
Status
Ongoing
Recall initiated
Mar 13, 2025
FDA report date
Apr 23, 2025
Quantity
4,010 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0365-2025, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
96470
Address
107 College Rd E
Code information
Lot: A1540076, Exp 08/31/2026
Postal code
08540-6623
Report date
Apr 23, 2025
Product type
Drugs
Recall number
D-0365-2025
Classification
Class I
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
4,010 bags
Reason for recall
LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland Pharma Limited, Hyderabad, - 500 043 INDIA, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-636-52
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 13, 2025
Center classification date
Apr 16, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0365-2025, published Apr 23, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls